RCS – Events

ResearchMatch

Posted on by

Did you know that UConn Health is part of the ResearchMatch Network? ResearchMatch.org is a national online recruitment tool, funded by the National Institutes of Health and maintained at Vanderbilt University. ResearchMatch connects interested participants with health-related research studies that might be a good “match” for them through its secure, online matching tool. There is no cost to UConn Health researchers who use ResearchMatch to conduct recruitment feasibility analysis or participant recruitment.

 

For more information, including the process for using ResearchMatch as a recruitment tool, visit our ResearchMatch webpage or contact Ellen Ciesielski in Research Integrity & Compliance.

“Human Pluripotent Stem Cells Twenty-Five Years On” Webinar

Posted on by

The discovery of human pluripotent stem cells just over twenty-five years ago almost immediately engendered widespread enthusiastic speculation concerning their future potential in research and medicine: a future as models for early human development, as platforms for functional human genomics, as tools for the study of disease, drug screening and toxicology, and as a renewable source of cellular therapeutics for a range of intractable diseases. In this lecture, Dr. Martin Pera, a noted expert in the pluripotent stem cell field, will assess the progress thus far and the prospects and challenges ahead.

The UConn/UConn Health Stem Cell Research Oversight (SCRO) Committee invites you to this one-hour lecture followed by a 30-minute Q&A session! 

Date: Monday, May 13, 2024

Time: 4:00 p.m. – 5:30 p.m. EDT

Presenter:  Dr. Martin Pera

Topic:  Human Pluripotent Stem Cells Twenty-Five Years On

Registration Link:  WebEx Registration Link

 

Martin Pera, Ph.D., The Jackson Laboratory

Martin Pera is a Professor at the Jackson Laboratory in Bar Harbor, Maine. He is the Chair of the Steering Group of the International Stem Cell Initiative, a member of the Board of Directors of the International Society for Stem Cell Research, and Editor-in-Chief of the society’s journal, Stem Cell Reports. His laboratory when at Monash University was the second in the world to isolate embryonic stem cells from the human blastocyst, and the first to describe their differentiation into somatic cells (neurons) in vitro. His current research is focused on understanding cell state transitions in pluripotent stem cells, and on the use of pluripotent stem cells to study disorders of the central nervous system and the development of cell therapy for age-related macular degeneration. Dr. Pera’s research interests are the cell biology of pluripotency and the applications of human pluripotent stem cells in disease modeling and therapy. 

 

For questions, contact Ellen Ciesielski, UConn/UConn Health SCRO Coordinator, Research Integrity & Compliance.

Questions about ClinicalTrials.gov?

Posted on by

ClinicalTrials.gov is an online database of clinical trials. At UConn Health, Principal Investigators are responsible for registering and posting results per the federal regulations as well journal policies. That National Institutes of Health definition of a clinical trial is a research study1  in which one or more human subjects2 are prospectively assigned3 to one or more interventions4 (which may include placebo or other control) to evaluate the effects of those interventions on health-related biomedical or behavioral outcomes.5  

Do you have questions about ClinicalTrials.gov registration or results posting? To schedule a virtual or in-person session with the UConn Health contact for ClinicalTrials.gov, email Ellen Ciesielski, Research Compliance Monitor in Research Integrity & Compliance in the OVPR. To learn more about ClinicalTrials.gov requirements, please see our webpages.

 

 

 

 

 

1See Common Rule definition of research at 45 CFR 46.102(d).
2See Common Rule definition of human subject at 45 CFR 46.102(f).
3The term “prospectively assigned” refers to a pre-defined process (e.g., randomization) specified in an approved protocol that stipulates the assignment of research subjects (individually or in clusters) to one or more arms (e.g., intervention, placebo, or other control) of a clinical trial.
4An intervention is defined as a manipulation of the subject or subject’s environment for the purpose of modifying one or more health-related biomedical or behavioral processes and/or endpoints.  Examples include:  drugs/small molecules/compounds; biologics; devices; procedures (e.g., surgical techniques); delivery systems (e.g., telemedicine, face-to-face interviews); strategies to change health-related behavior (e.g., diet, cognitive therapy, exercise, development of new habits); treatment strategies; prevention strategies; and, diagnostic strategies.
5Health-related biomedical or behavioral outcome is defined as the pre-specified goal(s) or condition(s) that reflect the effect of one or more interventions on human subjects’ biomedical or behavioral status or quality of life.  Examples include:  positive or negative changes to physiological or biological parameters (e.g., improvement of lung capacity, gene expression); positive or negative changes to psychological or neurodevelopmental parameters (e.g., mood management intervention for smokers; reading comprehension and /or information retention); positive or negative changes to disease processes; positive or negative changes to health-related behaviors; and, positive or negative changes to quality of life.

March Remote RCR Training 3/26

Posted on by

The Responsible Conduct of Research (RCR) Office within Research Integrity & Compliance in the OVPR hosts monthly remote RCR training sessions. For our March remote event, we will be discussing several case studies. This 1-hour event will count towards the 8-hour in person requirement for NIH, however all those who conduct research are strongly encouraged to attend!

For more details about RCR requirements, please visit our RCR Program website.

For questions, please contact Research Compliance Monitor, Ellen Ciesielski or Karen Moré, Director of Research Compliance.

What: March RCR remote training session featuring case study discussions

When: Tuesday, March 26th from 12:00 p.m. to 1:00 p.m.

Where: Remote WebEx Registration Link

March RCR Training

Posted on by

Calling All Human Subjects Research Staff! Please join the Responsible Conduct of Research (RCR) Office for our March in-person RCR training session with a focus on clinical and social researchers!

 

This month, we will be highlighting the importance of appropriately protecting research participants and avoiding research misconduct. We will meet in the library to view the Office of Research Integrity’s (ORI) interactive movie: “The Research Clinic.” Snacks will be provided!

 

The movie is designed as a “choose your own adventure”-type experience to allow participants to work through some common pitfalls and challenges in a low-risk environment. This 1.5-hour event will count towards the 8-hour in person requirement for NIH, but we highly encourage anyone conducting human subjects research to join us!

 

Space is limited so registration is required. To register, please email Research Compliance Monitor, Ellen Ciesielski.

What: March RCR in-person training, “The Research Clinic”

When: Wednesday, March 13th from 12:00 p.m. to 1:30 p.m.

Where: Babbidge Library, Class of ’47 Classroom

 

For questions, please contact Karen Moré, Director of Research Compliance. For more details about RCR requirements, please visit our RCR Office website.